Skip to main content
logo
Marksans Pharma Limited (NSE:MARKSANS)
India flag India · Delayed Price · Currency is INR
237.20
-4.85 (-2.00%)
Jul 23, 2025, 3:30 PM IST

Marksans Pharma Revenue

In the fiscal year ending March 31, 2025, Marksans Pharma had annual revenue of 26.23B INR with 20.46% growth. Marksans Pharma had revenue of 7.08B in the quarter ending March 31, 2025, with 26.51% growth.

Revenue
26.23B
Revenue Growth
+20.46%
P/S Ratio
4.18
Revenue / Employee
14.25M
Employees
1,840
Market Cap
109.69B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202526.23B4.45B20.46%
Mar 31, 202421.77B3.25B17.56%
Mar 31, 202318.52B3.61B24.23%
Mar 31, 202214.91B1.15B8.33%
Mar 31, 202113.76B2.42B21.32%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Sun Pharmaceutical Industries525.78B
Divi's Laboratories93.60B
Cipla272.67B
Mankind Pharma122.07B
Apollo Hospitals Enterprise217.94B
Zydus Lifesciences232.42B
Aurobindo Pharma317.24B
Glenmark Pharmaceuticals134.35B
Revenue Rankings

Marksans Pharma News

More News